Økonomisk evaluering av helseintervensjonar

Vitenskapelig artikkel

• Mori, Amani Thomas; Mudenda, Mweetwa; Robberstad, Bjarne et al. (2024). Impact of cash transfer programs on healthcare utilization and catastrophic health expenditures in rural Zambia: a cluster randomized controlled trial. (ekstern lenke)
• Veneti, Lamprini; Robberstad, Bjarne; Steens, Anneke et al. (2024). Social contact patterns during the early COVID-19 pandemic in Norway: insights from a panel study, April to September 2020. (ekstern lenke)
• Svege, Sarah; Rujumba, Joseph; Robberstad, Bjarne et al. (2024). "Whatever is bad goes back to the woman": The gendered blame game of sickle cell disease in Malawi and Uganda. (ekstern lenke)
• Hassan, Shoaib; Mustafa, Tehmina; Muller, William et al. (2024). Comparing the cost-effectiveness of the MPT64-antigen detection test to Xpert MTB/RIF and ZN-microscopy for the diagnosis of Extrapulmonary Tuberculosis: An economic evaluation modelling study. (ekstern lenke)
• Teigen, David; Opoka, Robert O.; Kasirye, Phillip et al. (2023). Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens. (ekstern lenke)
• Okell, Lucy C.; Kwambai, Titus K.; Dhabangi, Aggrey et al. (2023). Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa. (ekstern lenke)
• Nkosi-Gondwe, Thandile; Robberstad, Bjarne; Opoka, Robert et al. (2023). Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial. (ekstern lenke)
• Kühl, Melf-Jakob; Nkosi-Gondwe, Thandile; Ter Kuile, Feiko O. et al. (2023). Predicting adherence to postdischarge malaria chemoprevention in Malawian pre-school children: A prognostic multivariable analysis. (ekstern lenke)
• Phiri, Kamija S.; Khairallah, Carole; Kwambai, Titus Kimutai et al. (2023). Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trials. (ekstern lenke)
• Aarø, Leif Edvard; Veneti, Lamprini; Vedaa, Øystein et al. (2022). Visiting crowded places during the COVID-19 pandemic. A panel study among adult Norwegians. (ekstern lenke)
• Kühl, Melf-Jakob; Gondwe, Thandile; Dhabangi, Aggrey et al. (2022). Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysis. (ekstern lenke)
• Lund, Ulrikke Højslev; Stoinska-Schneider, Anna Karina; Larsen, Karianne et al. (2022). Cost-Effectiveness of Mobile Stroke Unit Care in Norway. (ekstern lenke)
• Kwambai, Titus K; Mori, Amani Thomas; Nevitt, Sarah et al. (2022). Post-discharge morbidity and mortality in children admitted with severe anaemia and other health conditions in malaria-endemic settings in Africa: a systematic review and meta-analysis. (ekstern lenke)
• Brendbekken, Audun; Robberstad, Bjarne; Norheim, Ole Frithjof (2022). Public participation: healthcare rationing in the newspaper media. (ekstern lenke)
• Tranvåg, Eirik Joakim; Haaland, Øystein Ariansen; Robberstad, Bjarne et al. (2022). Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage Decisions. (ekstern lenke)
• Lamu, Admassu Nadew; Björkman, Lars; Hamre, Harald Johan et al. (2022). Is amalgam removal in patients with medically unexplained physical symptoms cost-effective? A prospective cohort and decision modelling study in Norway. (ekstern lenke)
• Gondwe, Thandile; Robberstad, Bjarne; Mukaka, Mavuto et al. (2021). Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial. (ekstern lenke)
• Lamu, Admassu Nadew; Björkman, Lars; Hamre, Harald Johan et al. (2021). Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal. (ekstern lenke)
• Chamani, Amisa Tindamanyile; Mori, Amani Thomas; Robberstad, Bjarne (2021). Implementing standard antenatal care interventions: health system cost at primary health facilities in Tanzania. (ekstern lenke)
• Mwangi, Martin N; Mzembe, Glory; Moya, Ernest et al. (2021). Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial. (ekstern lenke)
• Lamu, Admassu Nadew; Robberstad, Bjarne; Hamre, Harald Johan et al. (2021). Validity and responsiveness of GHC-index in patients with amalgam-attributed health complaints. (ekstern lenke)
• Hussain, Hamidah; Malik, Amyn; Ahmed, Junaid F. et al. (2021). Cost-effectiveness of household contact investigation for detection of tuberculosis in Pakistan. (ekstern lenke)
• Chinkhumba, Jobiba Joe Henderson; De Allergi, Manuela; Brenner, Stephan et al. (2020). The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in Malawi. (ekstern lenke)
• Petkovic et al., Jennifer; Jull, Janet; Yoganathan, Manosila et al. (2020). Reporting of health equity considerations in cluster and individually randomized trials. (ekstern lenke)
• Kwambai, Titus Kimutai; Dhabangi, Aggrey; Idro, Richard et al. (2020). Malaria Chemoprevention in the Postdischarge Management of Severe Anemia. (ekstern lenke)
• Lamu, Admassu Nadew; Jbaily, Abdulrahman; Verguet, Stéphane et al. (2020). Is cycle network expansion cost-effective? A health economic evaluation of cycling in Oslo . (ekstern lenke)
• Solberg, Carl Tollef; Barra, Mathias; Robberstad, Bjarne (2020). Should we discount future health benefits? Pro et contra (English translation) . (ekstern lenke)
• Solberg, Carl Tollef; Barra, Mathias; Robberstad, Bjarne (2020). Bør vi diskontere fremtidige helsegevinster? Pro et contra . (ekstern lenke)
• Steens, Anneke; De Blasio, Birgitte Freiesleben; Veneti, Lamprini et al. (2020). Poor self-reported adherence to COVID-19-related quarantine/isolation requests, Norway, April to July 2020. (ekstern lenke)
• Svege, Sarah; Lange, Siri; Robberstad, Bjarne (2019). Malariaprofylakse til barn med alvorlig anemi redder liv – men hva er den beste leveringsmetoden på landsbygda i Malawi?. (ekstern lenke)
• Jull, Janet; Graham, Ian D.; Kristjansson, Elizabeth et al. (2019). Taking an integrated knowledge translation approach in research to develop the CONSORT-Equity 2017 reporting guideline: an observational study. (ekstern lenke)
• Hussain, Hamidad Farid; Mori, Amani Thomas; Khan, Aamir Javed et al. (2019). The cost-effectiveness of incentive-based active case finding for tuberculosis (TB) control in the private sector Karachi, Pakistan. (ekstern lenke)
• Loha, Eskindir; Deressa, Wakgari; Ayana, Taye Gari et al. (2019). Long-lasting insecticidal nets and indoor residual spraying may not be sufficient to eliminate malaria in a low malaria incidence area: Results from a cluster randomized controlled trial in Ethiopia. (ekstern lenke)
• Binyaruka, Peter John; Robberstad, Bjarne; Torsvik, Gaute et al. (2018). Who benefits from increased service utilisation? Examining the distributional effects of payment for performance in Tanzania. (ekstern lenke)
• Svege, Sarah; Kaunda, Blessings; Robberstad, Bjarne et al. (2018). Post-discharge malaria chemoprevention (PMC) in Malawi: caregivers` acceptance and preferences with regard to delivery methods methods. (ekstern lenke)
• Gondwe, Thandile; Robberstad, Bjarne; Mukaka, Mavuto et al. (2018). Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial. (ekstern lenke)
• Kwambai, Titus Kimutai; Dhabangi, Aggrey; Idro, Richard et al. (2018). Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: Study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial. (ekstern lenke)
• Gondwe, Thandile; Robberstad, Bjarne; Blomberg, Bjørn et al. (2018). Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers’ perceptions and motivation. (ekstern lenke)
• Binyaruka, Peter John; Robberstad, Bjarne; Torsvik, Gaute et al. (2018). Does payment for performance increase performance inequalities across health providers? A case study of Tanzania. (ekstern lenke)
• Hailu, Alemayehu; Lindtjorn, Bernt; Deressa, Wakgari et al. (2018). Cost-effectiveness of a combined intervention of long lasting insecticidal nets and indoor residual spraying compared with each intervention alone for malaria prevention in Ethiopia. (ekstern lenke)
• Hangoma, Peter; Aakvik, Arild; Robberstad, Bjarne (2017). Health Shocks and Household Welfare in Zambia: An Assessment of Changing Risk. (ekstern lenke)
• Jull, Janet E.G.; Whitehead, Margaret; Petticrew, Mark et al. (2017). When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework. (ekstern lenke)
• Mori, Amani Thomas; Kampata, Linda Milimo; Musonda, Patrick et al. (2017). Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial. (ekstern lenke)
• Chinkhumba, Jobiba Joe Henderson; De Allegri, Manuela; Mazalale, Jacob et al. (2017). Household costs and time to seek care for pregnancy related complications: The role of results-based financing. (ekstern lenke)
• Ngalesoni, Frida Namnyak; Ruhago, Georg Mugambage; Mayige, Mary T. et al. (2017). Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania. (ekstern lenke)
• Hangoma, Peter; Aakvik, Arild; Robberstad, Bjarne (2017). Explaining changes in child health inequality in the run up to the 2015 millennium development goals (MDGs): The case of Zambia. (ekstern lenke)
• Nankabirwa, Victoria; Tumwine, James K; Namugga, Olive et al. (2017). Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: Study protocol for a randomized controlled trial. (ekstern lenke)
• Hangoma, Peter; Robberstad, Bjarne; Aakvik, Arild (2017). Does Free Public Health Care Increase Utilization and Reduce Spending? Heterogeneity and Long-Term Effects. (ekstern lenke)
• Hailu, Alemayehu; Lindtjorn, Bernt; Deressa, Wakgari et al. (2017). Economic burden of malaria and predictors of cost variability to rural households in southcentral Ethiopia. (ekstern lenke)
• Mori, Amani Thomas; Norheim, Ole Frithjof; Robberstad, Bjarne (2016). Budget impact analysis of using dihydroartemisinin–piperaquine to treat uncomplicated malaria in children in Tanzania. (ekstern lenke)
• Ngalesoni, Frida Namnyak; Ruhago, Georg Mugambage; Mori, Amani Thomas et al. (2016). Equity impact analysis of medical approaches to cardiovascular diseases prevention in Tanzania. (ekstern lenke)
• Ngalesoni, Frida Namnyak; Ruhago, Georg Mugambage; Mori, Amani Thomas et al. (2016). Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: A Markov modelling study. (ekstern lenke)
• Deressa, Wakgari; Loha, Eskindir; Balkew, Meshesha et al. (2016). Combining long-lasting insecticidal nets and indoor residual spraying for malaria prevention in Ethiopia: Study protocol for a cluster randomized controlled trial. (ekstern lenke)
• Hailu, Alemayehu; Lindtjorn, Bernt; Deressa, Wakgari et al. (2016). Equity in long-lasting insecticidal nets and indoor residual spraying for malaria prevention in a rural South Central Ethiopia. (ekstern lenke)
• Ayana, Taye Gari; Kenea, Oljira; Loha, Eskindir et al. (2016). Malaria incidence and entomological findings in an area targeted for a cluster-randomized controlled trial to prevent malaria in Ethiopia: Results from a pilot study. (ekstern lenke)
• Ngalesoni, Frida; Ruhago, Georg; Norheim, Ole Frithjof et al. (2015). Economic cost of primary prevention of cardiovascular diseases in Tanzania. (ekstern lenke)
• Mazalale, Jacob; Kambala, Christabel; Brenner, Stephan et al. (2015). Factors associated with delivery outside a health facility: Cross-sectional study in rural Malawi. (ekstern lenke)
• Chola, Lumbwe; Fadnes, Lars T.; Engebretsen, Ingunn Marie S. et al. (2015). Cost-effectiveness of peer counselling for the promotion of exclusive breastfeeding in Uganda. (ekstern lenke)
• Ruhago, Georg; Ngalesoni, Frida Namnyak; Robberstad, Bjarne et al. (2015). Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania. (ekstern lenke)
• Nkonki, Lungiswa Leonora; Daviaud, Emmanuelle; Jackson, Debra et al. (2014). Costs of promoting exclusive breastfeeding at community level in three sites in South Africa. (ekstern lenke)

Rapport

• Evensen, Line Holtet; Kleven, Linn; Dahm, Kristin Thuve et al. (2023). Sutur av degenerative rotatorcuff-rupturer: en fullstendig metodevurdering. (ekstern lenke)
• Himmels, Jan Peter William; Flottorp, Signe Agnes; Stoinska-Schneider, Anna Karina et al. (2021). Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups: a health technology assessment . (ekstern lenke)
• Lund, Ulrikke Højslev; Bidonde, Julia; Kornør, Hege et al. (2021). Minimally Invasive Glaucoma Surgery (MIGS) for individuals with glaucoma. A health technology assessment . (ekstern lenke)
• Fagerlund, Beate Charlotte; Stoinska-Schneider, Anna; Lauvrak, Vigdis et al. (2019). Health technology assessment of Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk – Part 2. Health economic evaluation. (ekstern lenke)
• Kvist, Beate Charlotte Fagerlund; Chudasama, Kishan Kumar; Brurberg, Kjetil Gundro et al. (2019). Prosigna genprofiltest for å vurdere forventet nytte av kjemoterapi ved brystkreft. Vurdering av innsendt informasjon. (ekstern lenke)
• Ormstad, Sari Susanna; Lund, Ulrikke Højslev; Chudasama, Kishan Kumar et al. (2019). Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury. A health technology assessment. (ekstern lenke)
• Bidonde Torre, Maria Julia; Fagerlund, Beate Charlotte; Frønsdal, Katrine Bjørnebek et al. (2017). FreeStyle Libre-systemet for egenmåling av blodsukker: en hurtigmetodevurdering. (ekstern lenke)
• Stoinska-Schneider, Anna; Robberstad, Bjarne; Fure, Brynjar (2016). Mekanisk trombektomi ved akutt hjerneinfarkt del 2. Helseøkonomisk evaluering. (ekstern lenke)

Vitenskapelig foredrag

• Robberstad, Bjarne; Phiri, Kamija S. (2021). Symposium 3: Monthly malaria chemoprevention for the post-discharge management (PMC) of severe anaemia in children - Clinical evidence, effective implementation, acceptability, epidemiological consequences, cost-effectiveness and equity impact (introduction and overview). (ekstern lenke)
• Nkosi-Gondwe, Thandile; Robberstad, Bjarne; Mukaka, Mavuto et al. (2021). Effectiveness of community versus facility delivery of dihydroartemisinin-peraquine for post-discharge malaria chemoprevention in management of severe anaemia in Malawian children. (ekstern lenke)
• Kühl, Melf-Jakob; Ter Kuile, Feiko O.; Phiri, Kamija S. et al. (2021). Cost-effectiveness of PMC. (ekstern lenke)
• Mori, Amani Thomas; Okell, Lucy C; Kwambai, Titus Kimutai et al. (2021). Epidemiological impact of PMC. (ekstern lenke)
• Svege, Sarah; Kaunda, Blessings; Robberstad, Bjarne et al. (2021). Caregiver's acceptance and preferences with regard to delivery methods of PMC. (ekstern lenke)
• Phiri, Kamija; Robberstad, Bjarne (2019). Efficacy and Effectiveness of Post-Discharge Malaria Chemoprophylaxis in Kenya, Uganda, and Malawi: Preliminary report . (ekstern lenke)
• Kwambai, Titus Kimutai; Mori, Amani Thomas; Nevitt, Sarah et al. (2018). Post-discharge risks of morbidity and mortality in children in malaria endemic settings in Africa: A systematic review and meta-analysis - Oral presentation. (ekstern lenke)
• Kwambai, Titus Kimutai; Aggrey, Dhabangi; Idro, Richard et al. (2017). Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial.. (ekstern lenke)
• Kwambai, Titus Kimutai; Aggrey, Dhabangi; Idro, Richard et al. (2017). CPD Migori: Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial.. (ekstern lenke)
• Gondwe, Thandile; Robberstad, Bjarne; Mukaka, M et al. (2017). Delivery strategies of malaria chemoprevention for post-discharge management of children with severe anemia in Malawi (oral). (ekstern lenke)
• Binyaruka, Peter John; Torsvik, Gaute; Robberstad, Bjarne et al. (2017). Who benefits From Increased Service Utilization: Examining The Distributional Effects Of Payment For Performance in Tanzania. (ekstern lenke)
• Kwambai, Titus Kimutai; Aggrey, Dhabangi; Idro, Richard et al. (2016). CPD meeting: Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial. . (ekstern lenke)
• Binyaruka, Peter John; Torsvik, Gaute; Mæstad, Ottar et al. (2015). Equity effects of the Pay-for-Performance scheme among health facilities in Tanzania. (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Mori, Amani Thomas; Binyaruka, Peter; Hangoma, Peter et al. (2020). Patient and health system costs of managing pregnancy and birth-related complications in sub-Saharan Africa: A systematic review. (ekstern lenke)
• Chudasama, Kishan Kumar; Brurberg, Kjetil Gundro; Robberstad, Bjarne et al. (2019). Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission. (ekstern lenke)

Poster

• Kühl, Melf-Jakob; Pannu, Mehmajeet Kaur; ter Kuile, Feiko et al. (2019). Predicting parents’ adherence to malaria prophylaxis: a multivariable prediction model for caregivers’ adherence to post-discharge malaria chemoprophylaxis for children in Malawi . (ekstern lenke)
• Gondwe, Thandile; Robberstad, Bjarne; Mukaka, Mavuto et al. (2019). Effectiveness Of Community Versus Facility Delivery Strategies On Adherence To Dihydroartemesinin-Piperaquine For Post-Discharge Malaria Chemoprevention In Management Of Severe Anaemia In Malawian Children. (ekstern lenke)
• Gondwe, Thandile; Robberstad, Bjarne; Mukaka, Mavuto et al. (2019). Effectiveness Of Community Versus Facility Delivery Strategies On Adherence To Dihydroartemesinin-Piperaquine For Post-Discharge Malaria Chemoprevention In Management Of Severe Anaemia In Malawian Children. (ekstern lenke)
• Svege, Sarah; Kaunda, Blessings; Robberstad, Bjarne et al. (2018). Post-discharge malaria chemoprevention (PMC) in Malawi: caregivers` acceptance and preferences with regard to delivery methods methods. (ekstern lenke)
• Kwambai, Titus Kimutai; Aggrey, Dhabangi; Idro, Richard et al. (2017). Globvac: Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial. . (ekstern lenke)
• Svege, Sarah; Kaunda, Blessings N; Robberstad, Bjarne et al. (2017). Caretakers` acceptability of different delivery mechanisms of Post-discharge Malaria Chemoprevention (PMC) in Zomba, Southern Malawi A qualitative study under the GLOBVAC funded Post-discharge Malaria Chemoprevention Delivery (PMC) study . (ekstern lenke)
• Gondwe, Thandile; Robberstad, Bjarne; Mukaka, M et al. (2017). Delivery strategies of malaria chemoprevention for post-discharge management of children with severe anemia in Malawi (poster) . (ekstern lenke)

Mastergradsoppgave

• Shoaib, Hassan; Mustafa, Tehmina; Robberstad, Bjarne (2019). Pre-diagnostic cost of extrapulmonary tuberculosis from patient perspective in Zanzibar, Tanzania. (ekstern lenke)

Doktorgradsavhandling

• Chinkhumba, Jobiba Joe Henderson; Robberstad, Bjarne (2018). Economic analysis of Results-based financing in Malawi. Strengthening the evidence base for alternative maternal and perinatal Healthcare funding. (ekstern lenke)
• Hailu, Alemayehu; Robberstad, Bjarne (2018). Economic evaluation of malaria prevention in Ethiopia. Economic burden, equity, and cost-effectiveness analysis of malaria prevention in south-central Ethiopia. (ekstern lenke)
• Binyaruka, Peter John; Torsvik, Gaute; Robberstad, Bjarne (2018). Distributional effects of payment for performance in the health sector. Examining effects on structural quality, performance outcomes and service utilisation in Tanzania. (ekstern lenke)
• Hangoma, Peter; Robberstad, Bjarne; Aakvik, Arild (2017). Social Protection, Health Risk, and Household Welfare in Zambia. (ekstern lenke)
• Ruhago, George Mugambage; Norheim, Ole Frithjof; Robberstad, Bjarne (2015). Economic evaluation and equity impact analysis of interventions for maternal and child health in Tanzania. Evidence for fair and efficient priority setting. (ekstern lenke)
• Mori, Amani Thomas; Robberstad, Bjarne (2015). Pharmacoeconomics and Formulary Decision-Making in Tanzania. Generating Evidence for Antimalarial Drugs. (ekstern lenke)

Leserinnlegg

• Wisløff, Torbjørn; Robberstad, Bjarne (2015). Re: Markov-modellering :. (ekstern lenke)
• Robberstad, Bjarne (2015). B. Robberstad svarer :. (ekstern lenke)

Kronikk

• Robberstad, Bjarne (2015). Alder og alvor :. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin

Artiklar i fagfelleevaluerte tidsskrift

 

1. Mazalale, J., C Kambala, S Brenner, J Chinkhumba, J Lohmann, D Mathanga, B Robberstad, AS Muula and M de Allegri (2015). Factors associated with delivery outside a health facility: cross-sectional study in rural Malawi. Trop Med Int Health 20(5): 617-626.
2. Chola, L., LT Fadnes, IMS Engebretsen, L Nkonki, V Nankabirwa, H Sommerfelt, JK Tumwine, T Tylleskar and B Robberstad (2015). Cost-Effectiveness of Peer Counselling for the Promotion of Exclusive Breastfeeding in Uganda. PLoS One 10(11): e0142718.
3. Mori AT, Norheim OF, Robberstad B. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania. Pharmacoeconomics 2015.
4. Wisloff, T. and B. Robberstad (2015). Re: Markov-modellering. Tidsskr Nor Laegeforen 135(16): 1432.
5. B Robberstad.  Alder og alvor (Age and severity of disease). Tidsskr Nor Laegeforen. 2015 Aug 11; 1376 – 1378.
6. Ruhago, GM, FN Ngalesoni, B Robberstad and OF Norheim. Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania. BMC Cost-Effectiveness and Resource Allocation 2015, 13:7. DOI: 10.1186/s12962-015-0033-0.
7. Chinkhumba J, M Allegri, AS Muula and B Robberstad. Maternal and perinatal mortality by place of delivery in sub-Saharan Africa: a meta-analysis of population-based cohort studies. BMC Public Health 2014, 14:1014  doi:10.1186/1471-2458-14-1014.
8. Deressa W, E Loha, M Balkew, A Desalegne, T Gari, T Gebremichael, O Kenea, D Jima, B Robberstad, HJ Overgaard and B Lindtjørn. Poster presentation: Combining long-lasting insecticidal nets and indoor residual spraying for malaria prevention in Ethiopia: study protocol for a cluster randomized controlled trial. Malaria Journal, 09/2014; 13(suppl 1): P25. DOI: 10.1186/1475-2875-13-S1-P25.
9. Mori AT, F Ngalesoni, OF Norheim and B Robberstad. Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania. Malaria Journal, 09/2014; 13(1):363. DOI: 10.1186/1475-2875-13-363.
10. Ngalesoni F, G Ruhago, OF Norheimand B Robberstad. Economic cost of primary prevention of cardiovascular diseases in Tanzania.  Health Policy Plan. (2014), doi: 10.1093/heapol/czu088.
11. Nkonki LL, E Daviaud, D Jackson, L Chola, T Doherty, M Chopra and B Robberstad. Costs of Promoting Exclusive Breastfeeding at Community Level in Three Sites in South Africa. PLOS One. 2014; Vol 9 (1); e79784.
12. Mori AT, EA Kaale, F Ngalesoni, OF Norheim and B Robberstad. The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Coutries: The Case of Tanzania. PLOS One. 2014; Vol 9 (1); e84824.
13. B Robberstad, JE Askildsen and OF Norheim. Styrer budsjettkonsekvens norske refusjonsprioriteringar? (Are reimbursement priorities guided by budget impact?). Tidsskr Nor Laegeforen. 2013 Sep 17;133(17):1841-3. doi: 10.4045/tidsskr.13.0215.
14. Olsen JA, Kristiansen IS, J Magnussen, OF Norheim, B Robberstad. Fagkritikkens utfordringer (The challenges of subject criticism). Tidsskr Nor Laegeforen. 2013 Mar 5;133(5):499. Doi: 10.4045/tidsskr.13.0174.
15. AT Mori, P Gavaza and B Robberstad.  Role of pharmacoeconomics in developing countries. Editorial. Farmeconomia. Health economics and therapeutic pathways 2013; 14(1)
16. B Robberstad, Akselsen PE, Kværner KJ and Berstad A. Response to Reply to Economic evaluation of second generation pneumococcal conjugate vaccines in Norway. Letter. Vaccine. 2013 Jan 7;31(3):442-3.
17. Chola L, LT Fadnes, IMS Engebretsen, T Tylleskar and B Robberstad. Infant feeding survival and Markov transition probabilities among children 0–6 months in Uganda. American Journal of Epidemiology. February 2013, DOI: 10.1093/aje/kws254.
18. Mori AT and B Robberstad.  Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. BMC Medical Informatics and Decision Making. 2012;12: 110.
19. Robberstad B, CR Frostad, PE Akselsen, Kari J Kværner and Aud KH Berstad.  Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.  Vaccine 29 (2011): 8564-8574.
20. Chola L, L Nkonki, C Kankasa, J Nankunda, J Tumwine, T Tylleskar, B Robberstad, for the PROMISE-EBF Study Group. Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda and Zambia.  Cost Effectiveness and Resource Allocation 2011, 9:11.
21. Robberstad B and OF Norheim.  Incorporating concerns for equal lifetime health in evaluations of public health programs.  Social Science & Medicine, Volume 72, Issue 10, May 2011, Pages 1711-1716.
22. Nkonki LL, M Chopra, T Doherty, D Jackson, B Robberstad. Explaining household socio economic-related child health inequalities using multiple methods in three diverse settings in South Africa.  International Journal for Equity in Health, April 2011.
23. Robberstad B and BE Olsen. Cost-effectiveness of prevention of mother to child transmission of HIV (PMTCTplus) at Haydom Hospital in Tanzania – a prospective cost-effectiveness study. J Acquir Immune Defic Syndr. Aug 24 2010.
24. Robberstad B and JA Olsen (2010). The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study. Cost Eff Resour Alloc 8: 5 (11 p).
25. Johansson, K A, B Robberstad and OF Norheim. (2010). "Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy." AIDS Research and Therapy 7(1): 3 (9 p).
26. Chola L and Robberstad B. Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia. Cost Effectiveness and Resource Allocation, 2009, 7:16 (8p).
27. Bikilla AD, D Jerene, B Robberstad and B Lindtjørn. Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation, 2009, 7:13 (11p).
28. Bikilla AD, D Jerene, B Robberstad and B Lindtjørn. Cost estimates of HIV care and treatment with and without anti-retrovira thereapy at Arba Minch Hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation, 2009, 7:6 (7p).
29. Robberstad B, Y Hemed, and OF Norheim. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. Cost Effectiveness and Resource Allocation, 2007. 5: p. 3 (13p).
30. Robberstad B and Cairns J. Time preferences for health in northern Tanzania : an empirical analysis of alternative discounting models. Pharmacoeconomics, 2007. 25(1): p. 73-88.
31. Robberstad B. QALYs vs DALYs vs LYs gained:  What are the differences, and what difference do they make for health care priority setting?  Norwegian Epidemiology 2005; 15 (2): 183-191.
32. Wandwalo E, B Robberstad, O Morkve. Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Effectiveness and Resource Allocation 2005;3:6. 
33. Robberstad B. Estimation of private and social time preferences for health in northern Tanzania.Social Science and Medicine 2005; 61(7):1597-607.
34. Robberstad B, T Strand, RE Black, H Sommerfelt. Cost-effectiveness of zinc as adjunct therapy for acute childhood diarrhoea in developing countries. Bulletin of the World Health Organization 2004;82(7):523-31.
35. Kapiriri L, B Robberstad and OF Norheim.  The Relationship between prevention of Mother to Child Transmission of HIV and Stakeholder Decision Making in Uganda:  Implications for Health Policy.  Health Policy, 66, 199-211, 2003.

 

 

 

                                             

Bøker og bokkapittel    

        

 

1. Jan vd Broeck, J Brestoff, C Kaulfuss and B Robberstad. Statistical Modeling (40 pages). In: Jan vd Broeck and Jonathan Brestoff (eds). Epidemiology – Principles and practical guidelines. Springer Verlag; DOI 10.1007/978-94-007-5989-3_10.
2. Jan vd Broeck, J Brestoff, A Friedman, N Becker, M Hoaglin and B Robberstad. The measurement plan (43 pages). In: Jan vd Broeck and Jonathan Brestoff (eds). Epidemiology – Principles and practical guidelines. Springer Verlag; DOI 10.1007/978-94-007-5989-3_10.
3. Sanders D, B Hutton, T Njamhanga, K Heggenhougen, G Kvåle and B Robberstad (editors). Globalization and Health. Copyright © 2012, University of the Western Cape, University of Bergen, Muhimbili University of Health and Allied Sciences.
4. Robberstad B andY Hemed: Economic Evaluation of Health Interventions: Tanzania Perspectives. In Handbook of Disease Burden. Edited by Preedy VA. Heidelberg: Springer Verlag; 2009:547-586.
5. B Robberstad: Economic evaluation of health interventions in sub-Saharan Africa. Applied economic evaluations and studies on time preferences for health in Tanzania. Thesis, submitted to University of Bergen, 2005.

 

 

 

 

 

 

 

1. Malaria Chemoprevention for the post-discharge management of severe anaemia in children in Malawi, Uganda and Kenya (IPTpd): Moving towards policy.  Budget 32.8 mill NOK, Research council of Norway, 2014-2019

PhD Social Economics

Title of dissertation: Economic evaluation of health interventions in sub-Saharan Africa. Applied economic evaluations and studies on time preferences for health in Tanzania. Dissertation for the PhD degree. University of Bergen 2005.

MSc Developing Economics

Title of thesis: Time Toil and Soil - Time preferences and soil conservation practices in northern Tanzania. Norwegian University of Life Sciences 1997.